Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 9:8:742419.
doi: 10.3389/fmed.2021.742419. eCollection 2021.

T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease

Affiliations

T-Lymphocyte Subsets Alteration, Infection and Renal Outcome in Advanced Chronic Kidney Disease

Jiachuan Xiong et al. Front Med (Lausanne). .

Abstract

Background: T-lymphocyte subsets reflect patients' immune status and are associated with adverse outcomes in various diseases. However, the association between T-lymphocyte subsets and major infection and renal outcome in chronic kidney disease (CKD) patients has not been well-addressed. Methods: Patients diagnosed with stage 3-5 of non-dialysis CKD were recruited, and healthy subjects were selected as the controls. T-lymphocyte subsets (CD3+, CD4+, CD8+) were detected by flow cytometry, and the CD4+/CD8+ T cell ratio was then calculated. Patients were divided into the normal-level group and the low-level group according to the clinical reference value. The primary outcomes were the major infection and renal outcome. Results: A total of 410 CKD patients were enrolled; the average age was 47.25 years. Compared to the healthy controls, the level of CD3+, CD4+, CD8+ T cells, and the CD4+/CD8+ T cell ratio were significantly decreased in CKD patients (p < 0.05). During the median follow-up of 2.56 (quartile interval 1.24-3.46) years, major infections occurred in 15.10% of the CKD patients. The incidence of infection was significantly higher in the low-level group of CD3+, CD4+ T cells, and CD4+/CD8+ T cell ratio compared with the normal level groups. Kaplan-Meier analysis showed that the lower level of CD3+, CD4+ T cells, and CD4+/CD8+T cell ratio is associated with a greater risk of infection. Cox regression analysis further confirmed that low CD3+, CD4+ T cells, and CD4+/CD8+ T cell ratio were independent risk factors of infection in CKD patients. Moreover, during the follow-up, renal events occurred in 37.50% of patients. Kaplan-Meier analysis indicated that low levels of CD3+, CD4+, and CD8+ T cells are significantly associated with renal outcome in CKD patients. Cox regression analysis showed that low level of CD3+ T cells (HR = 2.407, 95% CI: 1.664-3.482, p < 0.001), CD4+ T cells (HR = 2.397, 95% CI: 1.633-3.518, p < 0.001) and CD8+ T cells (HR = 2.416, 95% CI: 1.476-3.955, p < 0.001) were independent risk factors for renal outcome after multivariable-adjusted. Conclusion: CKD patients had a defect in T-lymphocyte subpopulation. T-lymphocyte subsets were closely associated with infection and renal outcome in CKD patients. Suggesting T-lymphocyte subsets are independent predictors of infection and renal outcome in CKD patients.

Keywords: T-lymphocyte; chronic kidney disease; infection; renal outcome; risk factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Comparison of T-lymphocyte subsets between CKD patients and healthy subjects (HC). (A) CD3+ T cell count, (B) CD4+ T cell count, (C) CD8+ T cell count, (D) CD4+/CD8+ T cell ratio. The dotted line represented the normal value. **p < 0.01.
Figure 2
Figure 2
Association between T-lymphocyte subsets and major infection. (A) CD3+ T cell, (B) CD4+ T cell, (C) CD8+ T cell, (D) CD4+/CD8+ T cell. Patients were stratified into two groups by clinical reference value (Kaplan-Meier analysis with log-rank test).
Figure 3
Figure 3
The Hazard ratio for T-lymphocyte subsets with major infection (A) renal outcome (B) in CKD patients by multivariate-adjusted models.
Figure 4
Figure 4
Association between T-lymphocyte subsets and renal outcome. (A) CD3+ T cell, (B) CD4+ T cell, (C) CD8+ T cell, (D) CD4+/CD8+ T cell. Patients were stratified into two groups by clinical reference value (Kaplan-Meier analysis with log-rank test).

Similar articles

Cited by

References

    1. Murphy D, McCulloch CE, Lin F, Banerjee T, Bragg-Gresham JL, Eberhardt MS, et al. . Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. (2016) 165:473–81. 10.7326/M16-0273 - DOI - PMC - PubMed
    1. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, et al. . Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. (2012) 379:815–22. 10.1016/S0140-6736(12)60033-6 - DOI - PubMed
    1. Townsend RR, Anderson AH, Chirinos JA, Feldman HI, Grunwald JE, Nessel L, et al. . Association of pulse wave velocity with chronic kidney disease progression and mortality: findings from the CRIC study (Chronic Renal Insufficiency Cohort). Hypertension. (2018) 71:1101–7. 10.1161/HYPERTENSIONAHA.117.10648 - DOI - PMC - PubMed
    1. Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol. (2004) 24:469–73. 10.1016/j.semnephrol.2004.06.026 - DOI - PubMed
    1. Badiou S, Cristol JP, Jaussent I, Terrier N, Morena M, Maurice F, et al. . Fine-tuning of the prediction of mortality in hemodialysis patients by use of cytokine proteomic determination. Clin J Am Soc Nephrol. (2008) 3:423–30. 10.2215/CJN.02010507 - DOI - PMC - PubMed